Group 1 - On August 27, Taihe Co., Ltd. experienced a decline of 2.38% in stock price, with a trading volume of 168 million yuan [1] - The financing data for Taihe on the same day showed a financing purchase amount of 12.67 million yuan and a net financing purchase of 1.58 million yuan, with a total financing and securities balance of 57.41 million yuan [1] - The company’s main business includes the research, production, and sales of pesticide products and functional chemicals, with revenue composition being 43.14% herbicides, 37.30% fungicides, 9.98% functional chemicals, and 9.57% others [1] Group 2 - For the first half of 2025, Taihe Co., Ltd. reported a revenue of 2.41 billion yuan, representing a year-on-year growth of 23.15%, and a net profit attributable to shareholders of 182 million yuan, reflecting a year-on-year increase of 72.20% [1] - Since its A-share listing, Taihe has distributed a total of 180 million yuan in dividends [2] - As of June 30, 2025, Hong Kong Central Clearing Limited was the second-largest circulating shareholder, holding 401,900 shares as a new shareholder [2]

Core Viewpoint - Glyphosate has recently experienced a turnaround after three years of low prices, with a price increase from 22,000 yuan to 26,000 yuan per ton, marking an increase of nearly 20% [2][3]. Group 1: Price and Demand Dynamics - The price of glyphosate has significantly increased compared to the first quarter, driven by low industry inventory, the traditional export season to South America, and strong recovery demand after prolonged low prices [3]. - Glyphosate is primarily used in agricultural applications, accounting for over 90% of demand, with global production capacity at approximately 1.2 million tons annually, of which 380,000 tons are overseas and 810,000 tons are domestic [3]. - Export volume of glyphosate reached 331,000 tons in the first half of the year, a year-on-year increase of 14.2%, with export value at $970 million, up 11.1% year-on-year [3]. Group 2: Supply Chain and Cost Factors - The cost of raw materials, including caustic soda, has risen, with the average price of domestic yellow phosphorus at 23,300 yuan, an increase of 464 yuan compared to the previous year [4]. - There has been no new production capacity added in the glyphosate industry from 2018 to mid-2025, with effective domestic capacity expected to stabilize at around 800,000 tons [4]. - The industry is currently in a low inventory phase, with a significant reduction from 78,900 tons in early May to 30,600 tons by August 1 [5]. Group 3: Future Outlook - Glyphosate prices are expected to continue rising due to strong order intake from major companies and low inventory pressure [5]. - The market demand for glyphosate is anticipated to grow with the expansion of genetically modified crop planting and the banning of alternative herbicides [5]. - The competitive landscape of the industry is likely to improve due to uncertainties surrounding Monsanto's production capacity, potentially increasing market share for domestic leading companies [5].

Financial Performance - For the first half of 2025, the company's operating revenue reached approximately 3.36 billion, an increase from 3.17 billion in the same period last year, representing a growth of about 6.05% [1] - The total profit for the same period was approximately 419 million, up from 217 million year-on-year, indicating a significant increase of about 92.73% [1] - The net profit attributable to shareholders was approximately 338 million, compared to 171 million in the previous year, reflecting a growth of about 96.73% [1] - The net profit after deducting non-recurring gains and losses was approximately 277 million, up from 160 million, marking an increase of about 73.00% [1] - The net cash flow from operating activities was approximately 144 million, a year-on-year increase of about 53.1% [20] Profitability Metrics - The weighted average return on equity for the first half of 2025 was 8.71%, an increase of 4.08 percentage points compared to the previous year [16] - The return on invested capital for the same period was 5.75%, up by 2.38 percentage points year-on-year [16] Asset and Liability Changes - As of the end of the first half of 2025, the company's construction in progress increased by 37.55% compared to the end of the previous year, while inventory decreased by 36.87% [32] - Long-term borrowings increased by 35.02%, while contract liabilities decreased by 78.67% [35] - The company's liquidity ratios were reported as a current ratio of 1.22 and a quick ratio of 1.03 [42] Shareholder Composition - The top ten shareholders as of the end of the first half of 2025 included new entrants such as the National Social Security Fund and various investment funds, indicating a shift in shareholder structure [44] - The largest shareholder, Nantong Industrial Holdings Group, maintained a stable holding of approximately 12.47 million shares, representing about 28.96% of total shares [45] Valuation Metrics - As of the market close on August 25, the company's price-to-earnings ratio (TTM) was approximately 26.6, the price-to-book ratio (LF) was about 2.6, and the price-to-sales ratio (TTM) was around 1.85 [1]

召开的日期时间：2025 年 9 月 11 日 14 点 证券代码：600389 证券简称：江山股份 公告编号：临 2025-047 南通江山农药化工股份有限公司 关于召开2025年第三次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 召开地点：南通江山农药化工股份有限公司会议室（江苏省南通经济技术开 发区江山路 998 号） (五)网络投票的系统、起止日期和投票时间。 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (四)现场会议召开的日期、时间和地点 网络投票系统：上海证券交易所股东会网络投票系统 (七)涉及公开征集股东投票权 无 二、 会议审议事项 本次股东会审议议案及投票股东类型 投票股东类型 序号 议案名称 A 股股东 非累积投票议案 上述议案已经公司 2025 年 8 月 22 日召开的第九届董事会第二十一次会议 审议通过，详见公司 2025 年 8 月 26 日刊登于《中国证券报》、《上海证券报》 和上海证券交易所网站（www.sse.com.cn） ...

Core Points - The company plans to distribute a cash dividend of 4.50 yuan (including tax) for every 10 shares to all shareholders, amounting to a total of 193,792,500 yuan, which represents 57.25% of the net profit attributable to shareholders as of June 30, 2025 [1] Group 1: Financial Performance - Total assets increased by 3.77% from the previous year, reaching 8,959,450,738.43 yuan [2] - Operating revenue for the period was 3,359,091,481.62 yuan, reflecting a growth of 6.07% compared to the same period last year [2] - Total profit surged by 92.81% to 419,058,407.90 yuan [2] - Net profit attributable to shareholders increased by 73.19% to 276,982,344.36 yuan [2] - The net cash flow from operating activities was reported, but specific figures were not provided [2] Group 2: Shareholder Information - The total number of shareholders as of the report date was 21,035 [3] - The largest shareholder, Nantong Industrial Holdings Group Co., Ltd., holds 28.96% of the shares, totaling 124,728,141 shares [3] - Other significant shareholders include Sichuan Leshan Fuhua Crop Protection Technology Investment Co., Ltd. with 5.85% and various social security funds with smaller stakes [3]

Group 1 - The board of directors of Jiangshan Chemical Co., Ltd. held its 21st meeting of the 9th session on August 22, 2025, with all 9 directors participating in the voting [1][2] - The board approved the company's 2025 semi-annual report and summary, which was previously reviewed by the audit committee [1][2] - The board also approved the 2025 semi-annual profit distribution plan, which will be submitted to the shareholders' meeting for further review [2] - The board approved a proposal to expand the business scope and amend the company's articles of association, which will also be submitted to the shareholders' meeting [2] - A proposal to convene the third extraordinary shareholders' meeting of 2025 was approved by the board [2]

南通江山农药化工股份有限公司 2025 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露：第十三 号—化工》、《关于做好主板上市公司 2025 年半年度报告披露工作的重要提醒》 的要求，南通江山农药化工股份有限公司（以下简称"公司"）现将 2025 年半年 度主要经营数据披露如下： 注 1：上述产量含自用量、农药按含量折原药计算（下同）。 注 2：除草剂产品包括草甘膦、酰胺类等产品；杀虫剂产品包括敌百虫、敌敌畏、二嗪 磷等产品；氯碱产品包括烧碱、盐酸、液氯、次氯酸钠等产品，其中烧碱产销量 按 32%、48%烧碱实物量计算（下同）。 证券代码：600389 证券简称：江山股份 公告编号：临 2025-044 注 3：阻燃剂（磷系）产品包含 TCPP、BDP 产品（下同）。 | 主要产品 | 2025 | 年 | 1-6 月平 | 2024 月平 | 年 | 1-6 | 同期变动 | 第二季度环比 | | --- | --- | --- | - ...

Meeting Overview - The second extraordinary general meeting of shareholders was held on August 22, 2025, at the company's conference room in Nantong, Jiangsu Province [2] - The meeting was convened by the board of directors and chaired by Mr. Wang Li, with voting conducted through both on-site and online methods [2][3] Attendance - All 8 current directors attended the meeting, along with all 3 current supervisors and the company secretary [3] - The financial director attended as an observer [3] Resolutions Passed - The following resolutions were approved: 1. Proposal to cancel the supervisory board and amend the Articles of Association [4] 2. Proposal to formulate and amend certain governance systems [4] 3. Proposal to authorize the disposal of shares in affiliated companies [5] - The first proposal required a special resolution, which was passed with over two-thirds of the valid voting rights held by attending shareholders [5] Legal Verification - The meeting was witnessed by Beijing Wei Heng (Shanghai) Law Firm, confirming that the procedures complied with relevant laws and regulations [6] Employee Director Election - Mr. Fan Wenxin was elected as the employee director of the ninth board of directors, with his term starting from the approval date of the supervisory board cancellation proposal [8][9] - Mr. Fan has a background in economics and safety engineering, with no current shareholding in the company [10]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 南通江山农药化工股份有限公司 关于选举职工董事的公告 证券代码：600389 证券简称：江山股份 公告编号：临 2025—042 根据《中华人民共和国公司法》《中华人民共和国工会法》等相关法律法规规定， 为保证南通江山农药化工股份有限公司（以下简称"公司"）董事会的规范运作，经 公司第二十届职工代表大会第三次会议投票表决，同意选举樊文新先生为公司第九届 董事会职工董事（简历详见附件），任期自2025年第二次临时股东大会审议通过《关 于取消监事会暨修订 <公司章程> 的议案》之日起至公司第九届董事会任期届满之日止。 特此公告。 樊文新，男，1969 年出生，中国国籍，无境外永久居留权，研究生学历，经济师、 注册安全工程师。历任南通市经济贸易委员会科员、南通市安监局监督管理二处副处 长、政策法规处处长、公司副总经理、公司 HSE 总监、公司监事会主席、职工监事。 现任公司党委副书记、工会主席。 截至本公告披露日，樊文新先生未持有公司股份，与持有公司股份 5%以上股东、 其他董事 ...

Core Viewpoint - Yangnong Chemical reported a year-on-year increase in revenue and net profit for the first half of 2025, indicating positive growth trends in its financial performance [2]. Financial Performance - The company's revenue for the first half of 2025 was approximately 6.234 billion yuan, representing a year-on-year increase of 9.38% [2]. - The net profit attributable to shareholders was around 806 million yuan, showing a year-on-year increase of 5.6% [2]. - Basic earnings per share were reported at 1.996 yuan, which is a year-on-year increase of 6.29% [2].